Prologue: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2024 Annual Meeting [0.03%]
前言：2024年Psoriasis和Psoriatic关节炎研究与评估小组(GRAPPA)年度会议
Dafna D Gladman,Wilson Bautista-Molano,Denis Poddubnyy et al.
Dafna D Gladman et al.
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2024 annual meeting was held from July 11 to July 13, 2024, in Seattle, Washington, USA, and was attended by 256 rheumatologists, dermatologists, trainees, ...
Choice of biologic immunotherapy for psoriasis or psoriatic arthritis not associated with risk of major adverse cardiac events [0.03%]
生物制剂治疗银屑病或银屑病关节炎不会增加主要心血管不良事件的风险
Jack Geiger,Bonit Gill,Jean Liew et al.
Jack Geiger et al.
Objective: Individuals with psoriasis or psoriatic arthritis (PsO/PsA) have an elevated risk of major adverse cardiac events (MACE), which include congestive heart failure (CHF), myocardial infarction (MI), and cerebrovas...
Severe Symptoms Predict Residual Disease After Transitioning From High to Low Disease Activity in Axial Spondyloarthritis: A Longitudinal Study [0.03%]
重度症状可预测轴向型脊柱关节炎患者由高疾病活动度转为低疾病活动度后的残余病活跃性：一项纵向研究
Marius L Smits,Ellen Renet,Harald E Vonkeman et al.
Marius L Smits et al.
Objective: To investigate whether very high disease activity (VHDA) status or severe symptoms when in HDA state predict residual disease after achieving inactive disease/low disease activity (ID/LDA) in axial spondyloarth...
Nantakarn Pongtarakulpanit,Anuradha Bishnoi,Tanya Chandra et al.
Nantakarn Pongtarakulpanit et al.
Objective: Visual examination of skin lesions has considerable subjectivity and inter-rater variability. This study assessed the feasibility of a 3D image-based assessment of cutaneous disease activity in dermatomyositis ...
Confidence in the Use of Immunomodulatory Medications During Pregnancy: How Can Patient and Clinician Experience Be Improved? [0.03%]
孕期使用免疫调节药物的信心：如何改善患者和临床医生的体验？
Laura Andreoli,Mette Julsgaard,Karen Schreiber
Laura Andreoli
Renal AA Amyloidosis Associated With Systemic Lupus Erythematosus Treated With Anakinra [0.03%]
用于治疗安卡拉的系统性红斑狼疮伴肾AA淀粉样变性的病例研究报告
Jesús López-Martínez,Joan Esplugues Clos,Andrea Fernández-Valmaña et al.
Jesús López-Martínez et al.
Anifrolumab in Systemic Lupus Erythematosus With Severe Hematological Manifestations: A Spanish Multicenter Study [0.03%]
一种抗IFN制剂-Anifrolumab治疗严重血液系统损害的狼疮患者：西班牙多中心研究
Adrián Mayo-Juanatey,Santos Castañeda,Vanesa Calvo-Río et al.
Adrián Mayo-Juanatey et al.
Shaoyu Zheng,Zhuangyong Xu,Guangzhou Du et al.
Shaoyu Zheng et al.
GRAPPA 2024 Meeting: Advances in Psoriatic Disease Research From Pilot Grant Awardees [0.03%]
2024年GRAPPA会议：来自种子基金获得者的银屑病研究进展
Keith Colaco,Omar Alzayat,Steven Dang et al.
Keith Colaco et al.
Prioritizing and supporting trainee research in psoriatic disease (PsD) is a cornerstone of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). Each year, trainees and junior faculty are invited to submit pr...
Association of Frailty with Risk of Osteoarthritis Development, Progression and Worse Clinical Outcomes in Older Adults [0.03%]
脆弱性与老年成人骨关节炎发病、进展和不良临床结局风险的相关性研究
Jocelyn Waghorn,Selena P Maxwell,Sophie E Rayner et al.
Jocelyn Waghorn et al.
Objective: Both frailty and osteoarthritis become common with aging. Given their shared age-related incidence, we hypothesized that greater baseline frailty, measured by frailty index, would be associated with worse osteo...